Abu Dhabi building $150m biologics plant

- Last updated on GMT

A $150m (€100m) biologics manufacturing plant is being setup in Abu Dhabi to produce therapeutics for the Middle East and North Africa, according to the Khaleej Times.

The United Arab Emirates (UAE), which Abu Dhabi is part of, has made sizeable investments and offered incentives to boost its pharma industry, in part to diversify its industry beyond oil.

Emirates Biotech Pharmaceutical Factory, a new company, will setup the facility to produce crystal insulin for diabetes, anti-cancers, vaccines, haemophilia A and growth factors.

The facility will employ 200 people and is aiming to hire UAE nationals from local universities and technical institutes. Emirates Biotech intends to export 80 per cent of products to Middle Eastern countries, with the remainder being sold in the UAE and other Arabian Gulf nations.

Related topics: Ingredients

Related news